Heart Rhythm Society (HRS)

The Heart Rhythm Society (HRS) is the primary U.S. medical society for electrophysiology (EP). The organization promotes education and advocacy for cardiac arrhythmia professionals and patients, including setting policy guidelines and offering expert consensus.

New hypertrophic cardiomyopathy guidelines highlight importance of exercise, new drug class
HCM is widely underdiagnosed, but the American College of Cardiology and American Heart Association hope their new guidelines can help cardiologists learn more about the potentially fatal condition and improve patient care.
HRS 2024: Late-breaking clinical trials will highlight key trends in electrophysiology
A total of 21 late-breaking science presentations are scheduled for Heart Rhythm 2024 in Boston.
Cardiology groups share key update: ABMS seeking feedback on proposed Board of Cardiovascular Medicine
Five of the largest U.S. medical societies focused on cardiovascular health are one step closer to seeing their paradigm-shifting proposal become a reality.
Cardiology groups want to ‘transform the future of cardiovascular medicine’ with new medical board
Leaders from the American Heart Association, American College of Cardiology, Heart Failure Society of America, Heart Rhythm Society and Society for Cardiovascular Angiography & Interventions have shared their vision for a new, independent Board of Cardiovascular Medicine.
Why long-term EP lead management is as important as ever
Anne Kroman, DO, PhD, noted that early, aggressive treatment is critical when EP leads need to be removed.

New Study Demonstrates Feasibility of Novel Mechanical Sensor in Medtronic Micra Transcatheter Pacing System to Detect Atrial Contractions and Restore AV Synchrony

DUBLIN and BOSTON — May 11, 2018 — Medtronic plc (NYSE:MDT) today announced new clinical study results demonstrating that an investigational algorithm, utilizing the accelerometer signal in the Micra(TM) Transcatheter Pacing System (TPS) may restore AV synchrony, improving cardiac function in patients with sinus rhythm and atrioventricular (AV) block.

May 14, 2018

AFib ablation outperforms drugs in CABANA trial

Catheter ablation was found to be superior to optimal drug therapy for the primary treatment of atrial fibrillation (AFib) in the randomized CABANA trial presented May 10 at the Heart Rhythm Society’s annual scientific sessions in Boston. However, there was a caveat.

May 11, 2018

Study Shows Positive Results with Medtronic Cryoballoon for Patients with Persistent Atrial Fibrillation

DUBLIN and BARCELONA, Spain - MARCH 19, 2018 - Medtronic plc (NYSE: MDT) today announced one-year results from the CRYO4PERSISTENT AF study of ablation with the Arctic Front Advance(TM) Cryoballoon to isolate the pulmonary veins in patients with symptomatic persistent atrial fibrillation (AF).

March 19, 2018

Heart Rhythm Society (HRS)

New hypertrophic cardiomyopathy guidelines highlight importance of exercise, new drug class

HRS 2024: Late-breaking clinical trials will highlight key trends in electrophysiology

Cardiology groups share key update: ABMS seeking feedback on proposed Board of Cardiovascular Medicine

Cardiology groups want to ‘transform the future of cardiovascular medicine’ with new medical board

Why long-term EP lead management is as important as ever